Drug
Ion363
Ion363: highest development phase Phase 3, developed by Ionis Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ionis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ION363 NCT04768972 | Phase 3 | Amyotrophic Lateral Sclerosis |
Latest
No recent events.
Follow Ion363 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.